Details
August 28, 2019
8:30AM - 10:00AM
Sundowners Syndrome: Improving Outcomes for At-Risk Populations In the Home, In Hospice, and in Long-Term Care
Concurrent Session 4A
Juniper A
Sundowners Syndrome: Improving Outcomes for At-Risk Populations In the Home, In Hospice,
and in Long-Term Care
Cleanne Cass, DO, FAAHPM, FAAFP, Ohio's Hospice of Dayton; Daniel Swagerty, MD, MPH, FAAFP, AGSF, Wright State University, Boonshoft School of Medicine; Mustafa Rayaz, DO, Premier Health
Sundowners Syndrome affects over 66% of patients with dementia at some time in the course of their illness. It is devastating and one of the two major reasons for institutionalization of patients with dementia. Sundowners Syndrome carries a high risk of morbidity and mortality. This session will explore the nature of Sundowners Syndrome, differentiate it from similar conditions and explore treatment options and management of patients in various settings. State and federal regulatory requirements that may impact treatment options will be discussed. Best practices to improve outcomes for the patient, family and for staff will be shared.
4A: Handout
Printer-Friendly Version
Add to Calendar
aCLuDhaqizCaPxAftmqF167204
08/28/2019 08:30 AM
08/28/2019 10:00 AM
false
Sundowners Syndrome: Improving Outcomes for At-Risk Populations In the Home, In Hospice, and in Long-Term Care
Sundowners Syndrome: Improving Outcomes for At-Risk Populations In the Home, In Hospice,and in Long-Term CareCleanne Cass, DO, FAAHPM, FAAFP, Ohio's Hospice of Dayton; Daniel Swagerty, MD, MPH, FAAFP, AGSF, Wright State University, Boonshoft School of Medicine; Mustafa Rayaz, DO, Premier Health
Sundowners Syndrome affects over 66% of patients with dementia at some time in the course of their illness. It is devastating and one of the two major reasons for institutionalization of patients with dementia. Sundowners Syndrome carries a high risk of morbidity and mortality. This session will explore the nature of Sundowners Syndrome, differentiate it from similar conditions and explore treatment options and management of patients in various settings. State and federal regulatory requirements that may impact treatment options will be discussed. Best practices to improve outcomes for the patient, family and for staff will be shared.
4A: Handout
Juniper A
